GHIT Fund Announces New Investments: A Total of 2.86 Billion Yen in Drug for Schistosomiasis, Dengue, Malaria and Tuberculosis, Vaccines for Leishmaniasis and Malaria, and Diagnostics for Tuberculosis

GHIT Fund Announces New Investments: A Total of 2.86 Billion Yen in Drug for Schistosomiasis, Dengue, Malaria and Tuberculosis, Vaccines for Leishmaniasis and Malaria, and Diagnostics for Tuberculosis - PRNewswire

March 29, 2019

GHIT Fund Announces New Investments: A Total of 2.86 Billion Yen in Drug for Schistosomiasis, Dengue, Malaria and Tuberculosis, Vaccines for Leishmaniasis and Malaria, and Diagnostics for Tuberculosis PRNewswire

TOKYO, March 27, 2019 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total of 2.86 billion yen (US$25.8 million*) ...

Search This Blog

Causes of Schistosomiasis

GHIT Fund Announces New Investments: A Total of 2.86 Billion Yen in Drug for Schistosomiasis, Dengue, Malaria and Tuberculosis, Vaccines for Leishmaniasis and Malaria, and Diagnostics for Tuberculosis - PRNewswire

Comments

Post a Comment

Popular posts from this blog

How fat prawns can save lives: Small-scale farming of freshwater crustaceans could be a win-win for communities where schistosomiasis is common - Science Daily

How fat prawns can save lives: Small-scale farming of freshwater crustaceans could be a win-win for communities where schistosomiasis is common - Science Daily

How fat prawns can save lives: Small-scale farming of freshwater crustaceans could be a win-win for communities where schistosomiasis is common - Science Daily